Based on ratings from 23 stock analysts, the Medtronic PLC stock price is expected to increase by 8.84% in 12 months. This is calculated by using the average 12-month stock price forecast for Medtronic PLC. The lowest target is $82 and the highest is $110.12. Please note analyst price targets are not guaranteed and could be missed completely.
About 23 Wall Street analysts have assignedMDT 11 buy ratings, 12 hold ratings, and 0 sell ratings. This means that analysts expect Medtronic PLC to hold. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on MDT. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of MDT.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Mike Matson Needham | Hold | Reiterates | Oct 25, 2024 | |
Richard Newitter Truist Securities | Hold | $93 | Maintains | Oct 14, 2024 |
Shagun Singh RBC Capital | Outperform | $105 | Upgrade | Oct 10, 2024 |
Shagun Singh RBC Capital | Sector Perform | $98 | Maintains | Oct 8, 2024 |
Joanne Wuensch Citigroup | Neutral | $92 | Maintains | Oct 1, 2024 |
Vijay Kumar Evercore ISI Group | Outperform | $104 | Maintains | Oct 1, 2024 |
Richard Newitter Truist Securities | Hold | $90 | Maintains | Aug 23, 2024 |
Matt Miksic Barclays | Overweight | $105 | Maintains | Aug 22, 2024 |
Rick Wise Stifel | Hold | $87 | Maintains | Aug 21, 2024 |
Matt O'Brien Piper Sandler | Neutral | $90 | Maintains | Aug 21, 2024 |
Shagun Singh RBC Capital | Sector Perform | $92 | Reiterates | Aug 21, 2024 |
David Rescott Baird | Neutral | $90 | Maintains | Aug 21, 2024 |
Steven Lichtman Oppenheimer | Perform | $94 | Maintains | Aug 21, 2024 |
Larry Biegelsen Wells Fargo | Overweight | $106 | Maintains | Aug 21, 2024 |
Mike Matson Needham | Hold | Reiterates | Aug 20, 2024 | |
Danielle Antalffy UBS | Neutral | $90 | Upgrade | Aug 15, 2024 |
Rick Wise Stifel | Hold | $85 | Downgrade | Aug 14, 2024 |
Mike Matson Needham | Hold | Reiterates | Aug 12, 2024 | |
Shagun Singh RBC Capital | Sector Perform | $92 | Reiterates | Jul 17, 2024 |
Richard Newitter Truist Securities | Hold | $85 | Maintains | Jul 16, 2024 |
When did it IPO
1981
Staff Count
95,000
Country
Ireland
Sector/Industry
Healthcare/Medical Devices
CEO
Mr. Geoffrey Straub Martha
Market Cap
$113.07B
In 2023, MDT generated $31.23B in revenue, which was a decrease of -1.45% from the previous year. This can be seen as a signal that MDT's business is declining, and its share price could be worth less in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - Oracle, Micron Technology, Medtronic, and The Cato are highlighted in a recent analyst blog, potentially indicating investment opportunities or insights.
Why It Matters - Inclusion of Oracle, Micron Technology, Medtronic, and Cato in an analyst blog suggests potential investment opportunities or insights, possibly influencing stock performance and market sentiment.
Summary - Medtronic (MDT) closed at $87.72, down 0.45% from the previous trading day.
Why It Matters - Medtronic's slight decline may indicate market concerns or shifting investor sentiment, potentially impacting future stock performance and investment strategies.
Summary - Medtronic plc (NYSE:MDT) will report its Q2 fiscal 2025 financial results on November 19, 2024, with a news release scheduled for 5:45 a.m. EST.
Why It Matters - Medtronic's upcoming financial results may impact its stock price and investor sentiment, signaling performance trends and potential growth or challenges in the healthcare sector.
Summary - Medtronic's fiscal second-quarter profits may have been negatively affected by the current geopolitical situation, similar to other companies in the sector.
Why It Matters - Geopolitical tensions could negatively affect Medtronic's Q2 profits, signaling potential financial instability and impacting stock performance and investor confidence.
Summary - Investors often seek dividend-yielding stocks during market turbulence, as these companies typically have high free cash flows and provide substantial dividends.
Why It Matters - Dividend-yielding stocks provide stability and income during market volatility, appealing to investors seeking reliable returns and companies with strong cash flows.
Summary - The article highlights stocks that are considered stable and reliable, providing investors with peace of mind regarding their investments.
Why It Matters - Stocks identified as stable can reduce portfolio volatility, providing a sense of security and potential for steady returns, appealing to risk-averse investors.